|
ZNF391 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26299999999124E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.205800E-02 |
| Normal-vs-Stage2 |
3.601600E-04 |
| Normal-vs-Stage3 |
1.86209999974984E-07 |
| Normal-vs-Stage4 |
1.791380E-04 |
| Stage1-vs-Stage2 |
2.974200E-02 |
| Stage1-vs-Stage3 |
7.411900E-04 |
| Stage1-vs-Stage4 |
2.347600E-02 |
| Stage2-vs-Stage3 |
9.671800E-01 |
| Stage2-vs-Stage4 |
8.424600E-01 |
| Stage3-vs-Stage4 |
8.293600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.60199999999345E-05 |
| Normal-vs-AfricanAmerican |
1.499500E-03 |
| Normal-vs-Asian |
8.236600E-01 |
| Caucasian-vs-AfricanAmerican |
2.368200E-01 |
| Caucasian-vs-Asian |
4.446200E-01 |
| AfricanAmerican-vs-Asian |
2.879600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.595400E-04 |
| Normal-vs-Female |
1.51281999999364E-05 |
| Male-vs-Female |
1.680410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.687900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.883600E-03 |
| Normal-vs-Age(61-80Yrs) |
4.21240000003653E-06 |
| Normal-vs-Age(81-100Yrs) |
4.361500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.583600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.210600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.256000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.225990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.844030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.925200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.961200E-01 |
| Normal-vs-Grade 2 |
1.254290E-02 |
| Normal-vs-Grade 3 |
3.572800E-04 |
| Normal-vs-Grade 4 |
2.92219581865538E-11 |
| Grade 1-vs-Grade 2 |
3.147400E-01 |
| Grade 1-vs-Grade 3 |
7.121900E-02 |
| Grade 1-vs-Grade 4 |
2.791600E-02 |
| Grade 2-vs-Grade 3 |
1.959640E-01 |
| Grade 2-vs-Grade 4 |
3.33929999984939E-07 |
| Grade 3-vs-Grade 4 |
1.617870E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.158600E-01 |
| Normal-vs-ccB subtype |
2.07110000038924E-07 |
| ccA subtype-vs-ccB subtype |
7.60990000000517E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.447000E-04 |
| Normal-vs-N1 |
2.165900E-02 |
| N0-vs-N1 |
1.807560E-01 |
|
|
